Cart
sales@molnova.com
Tesnatilimab
CAS No. 2242758-08-1
Tesnatilimab( —— )
Catalog No. M36880 CAS No. 2242758-08-1
Tesnatilimab is a potent humanized IgG4 monoclonal antibody that binds to the immune-activating receptor NKG2D.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 560 | In Stock |
|
| 10MG | 911 | In Stock |
|
| 25MG | 1349 | In Stock |
|
| 50MG | 1786 | In Stock |
|
| 100MG | 2409 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameTesnatilimab
-
NoteResearch use only, not for human use.
-
Brief DescriptionTesnatilimab is a potent humanized IgG4 monoclonal antibody that binds to the immune-activating receptor NKG2D.
-
DescriptionTesnatilimab is a human IgG4 monoclonal antibody that acts on the immune activating receptor NKG2D and has potential immunomodulatory and anti-inflammatory activity. Tesnatilimab can be used in the study of inflammatory bowel disease (IBD).
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2242758-08-1
-
Formula Weight
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Kasper Vadstrup, et al. Anti-NKG2D mAb: A New Treatment for Crohn's Disease? Int J Mol Sci. 2017 Sep 16;18(9):1997.?
molnova catalog
related products
-
GSK2850163
GSK2850163 is a novel inhibitor of inositol-requiring enzyme-1 alpha (IRE1α) which can inhibit RNase activity and IRE1α kinase activity (IC50s: 200 and 20 nM).
-
KB-R7943
KB-R7943 mesylate is a widely used inhibitor of the reverse Na+/Ca2+ exchanger (NCXrev) with IC50 of 5.7±2.1 μM.
-
regaloside I
Regaloside I is the monomeric component in lily. Regaloside I could be the main constituent in protecting human dermal fibroblasts from UVA-induced morphological changes .
